Media release
From:
Journal/
conference: Respirology
conference: Respirology
Research:Paper
Organisation/s:
The University of Melbourne, University of Tasmania, The University of New South Wales, Monash University
Funder:
This study was supported by the
National Health and Medical Research Council (NHMRC)
of Australia under NHMRC project grant scheme (299901,
1021275) and NHMRC European collaborative grant
scheme (1101313) as part of ALEC (Ageing Lungs in
European Cohorts funded by the European Union’s Horizon
2020 research and innovation programme under grant
agreement No. 633212); The University of Melbourne; Clifford
Craig Medical Research Trust of Tasmania; The
Victorian, Queensland & Tasmanian Asthma Foundations;
The Royal Hobart Hospital; Helen MacPherson Smith Trust;
and GlaxoSmithKline. The funding agencies had no direct
role in the conduct of the study, the collection, management,
statistical analysis and interpretation of the data, preparation
or approval of the manuscript. Open access publishing
facilitated by The University of Melbourne, as part of the
Wiley - The University of Melbourne agreement via the
Council of Australian University Librarians.
CONFLICTS OF INTEREST
Michael Abramson received grants from Pfizer. Sanofi, GSK
and Boehringer Ingelheim outside the submitted work.
Other authors had not disclosed any conflicts of interest.
Caroline Lodge, E. Haydn Walters, Adrian Lowe, Dinh Bui,
Michael Abramson, Jennifer Perret ad Shyamali Dharmage
hold an investigator-initiated grant from GlaxoSmithKline
for unrelated research. Adrian Lowe has received non-financial
support from Primus Pharmaceuticals for unrelated
research.